Suntas Pharma Ltd
07391349
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 13/11/2023
MOLECULAR BIOLOGIST
BRITISH · ENGLAND · Age 35
Also on 4 other boards
Persons with Significant Control
Miss Selin Koca
British · England · Age 35
338a, Regents Park Road, London, N3 2LN
Notified 13/11/2023
Former PSCs
Mr Mohammed Taseen
Ceased 13/11/2023
Sabre Healthcare Ltd
Ceased 25/09/2022
CompanyRankvs 15273+ SIC 46900 peers39
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2024
Net Worth
-£279k
Balance sheet strength
Cash
£6k
Cash in the bank
Net Current Assets
-£143k
Working capital
Current Assets
£46k
Current Liabilities
£189k
Fixed Assets
£95k
Debtors
£8k
Tax at Year End(2020)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 0.24 | -£518k |
| 2023 | 0.12 | +£197k |
| 2022 | 1.08 | -£8k |
| 2021 | 8.39 | -£18k |
| 2020 | 4.83 | +£20k |
| 2019 | 3.43 | — |
Derived from filed accounts. Not audited figures.